Real-world immuno-oncology (IO) therapy treatment patterns and outcomes in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) in the United States

X. Pan, M. M. Lin, Y. Yin, P. Hou, P. Baumann, M. Jahanzeb

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)ii52-ii53
JournalAnnals of Oncology
Volume30
DOIs
StatePublished - Apr 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this